Cargando…
Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213775/ https://www.ncbi.nlm.nih.gov/pubmed/37251327 http://dx.doi.org/10.3389/fphar.2023.1199951 |
| _version_ | 1785047700107952128 |
|---|---|
| author | Guo, Zhou Lin, Jiamin Sun, Kai Guo, Jiayou Yao, Xudong Wang, Genchun Hou, Liangcai Xu, Jingting Guo, Jiachao Guo, Fengjing |
| author_facet | Guo, Zhou Lin, Jiamin Sun, Kai Guo, Jiayou Yao, Xudong Wang, Genchun Hou, Liangcai Xu, Jingting Guo, Jiachao Guo, Fengjing |
| author_sort | Guo, Zhou |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10213775 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102137752023-05-27 Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway Guo, Zhou Lin, Jiamin Sun, Kai Guo, Jiayou Yao, Xudong Wang, Genchun Hou, Liangcai Xu, Jingting Guo, Jiachao Guo, Fengjing Front Pharmacol Pharmacology Frontiers Media S.A. 2023-05-12 /pmc/articles/PMC10213775/ /pubmed/37251327 http://dx.doi.org/10.3389/fphar.2023.1199951 Text en Copyright © 2023 Guo, Lin, Sun, Guo, Yao, Wang, Hou, Xu, Guo and Guo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Guo, Zhou Lin, Jiamin Sun, Kai Guo, Jiayou Yao, Xudong Wang, Genchun Hou, Liangcai Xu, Jingting Guo, Jiachao Guo, Fengjing Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway |
| title | Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway |
| title_full | Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway |
| title_fullStr | Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway |
| title_full_unstemmed | Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway |
| title_short | Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway |
| title_sort | corrigendum: deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the nrf2 pathway |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213775/ https://www.ncbi.nlm.nih.gov/pubmed/37251327 http://dx.doi.org/10.3389/fphar.2023.1199951 |
| work_keys_str_mv | AT guozhou corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT linjiamin corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT sunkai corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT guojiayou corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT yaoxudong corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT wanggenchun corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT houliangcai corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT xujingting corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT guojiachao corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT guofengjing corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway |